CRP,CRP/Alb Ratio, N/L Ratio in Predictors of Both Systemic Infection and Survival in Patient with Sepsis in Assiut University Hospitals

Launched by ASSIUT UNIVERSITY · Sep 4, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how certain biomarkers in the blood can help predict the outcomes for patients with sepsis, a serious condition caused by an infection that can lead to organ failure. The specific biomarkers being studied are CRP, CRP/Alb ratio, and N/L ratio. The main goal is to find out if these markers can indicate how well patients with sepsis, who have normal blood pressure, will respond to treatment and survive.

To participate in this trial, patients must be diagnosed with sepsis but should not have low blood pressure or have recently received certain treatments like steroids or antibiotics. They should also not have specific blood disorders or recent cancer treatments. The trial is not yet recruiting participants, but those who qualify can expect to contribute valuable information that could help improve care for future patients with sepsis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with sepsis with normal blood pressure
• Exclusion Criteria:
• • 1) Patients with history of corticosteroid therapy or antibiotic use before admission.
• • 2) Patients with hematologic disorders, malignant diseases, chemotherapy or radiotherapy within the previous month .
• • 3)Patients with shock